cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pardes Biosciences Inc
2 watching
Current Price
$1.71
$-0.07
(-3.93%)
logo-prds
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
101.08M
52-Week High
52-Week High
13.135
52-Week Low
52-Week Low
0.75
Average Volume
Average Volume
0.1M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization101.08M
icon52-Week High13.135
icon52-Week Low0.75
iconAverage Volume0.1M
iconDividend Yield--
iconP/E Ratio--
What does the Pardes Biosciences Inc do?
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.
Read More
How much money does Pardes Biosciences Inc make?
News & Events about Pardes Biosciences Inc.
Globe Newswire
2days ago
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"): Skillsoft Corp. f/k/a Churchill Capital Corporation II (NYSE: SKIL), OppFi Inc. ...
Globe Newswire
11days ago
SAN DIEGO, Jan. 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"): Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II (NYSE: KIND), ...
Ticker Report
2 months ago
Pardes Biosciences, Inc. (NASDAQ:PRDS Get Rating) Equities research analysts at SVB Leerink lifted their FY2024 EPS estimates for shares of Pardes Biosciences in a report issued on Monday, November 7th. SVB Leerink analyst R. Ruiz now forecasts that the company will post earnings per...
Globe Newswire
4 months ago
CARLSBAD, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone, novel direct-acting, oral antiviral drug candidate for the treatment and prevention of SARS-CoV-2 infections and ...
Zolmax
5 months ago
Pardes Biosciences (NASDAQ:PRDS Get Rating) had its price target dropped by investment analysts at SVB Leerink from $18.00 to $12.00 in a research report issued on Tuesday, MarketBeat.com reports. The firm presently has an outperform rating on the stock. SVB Leerinks price objective indicates a ...
Frequently Asked Questions
Frequently Asked Questions
What is Pardes Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Pardes Biosciences Inc shares?
plus_minus_icon
How can I buy Pardes Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Pardes Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pardes Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Pardes Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Pardes Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pardes Biosciences Inc?
plus_minus_icon
What percentage is Pardes Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pardes Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.71
$-0.07
(-3.93%)
logo-prds
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00